Today

Agents

Chat

Arena

Discover

More

App

Myriad Genetics target price raised to $8 from $5 by Leerink Partners

MYGN•2026-11-05

Leerink Partners raised its target price for Myriad Genetics to $8 from $5.

Related News

A

Amplitude, Inc.: Raymond James raises target price to $22 from $13

AMPL•2026-11-05

Chime Financial, Inc.: Scotiabank raises target price to $44 from $42

CHYM•2026-11-05

Australia, NZ dollars extend gains as US Democratic sweep fuels risk rally

SPY•2026-11-05

Canaccord Genuity cuts Uber target price to $70 from $72

UBER•2026-11-05

J.P. Morgan Securities raises Nepes Ark holding to 665,517 shares

JPM•2026-11-05

Myriad Genetics target price raised to $8 from $5 by Leerink Partners - MYGN News | Rallies